化脓性汗腺炎的外科治疗:一项两中心回顾性研究
该两中心回顾性研究分析了2005至2020年间接受手术切除的化脓性汗腺炎患者,共181例患者、435例次手术和316个治疗周期,94%的治疗周期实现创面闭合与愈合,并描述了多种闭合技术,作者认为手术是有效疗法,可为未来前瞻性研究和循证指南提供基础。
要点
- 两中心共纳入181例患者、435例次手术、316个治疗周期,94%的治疗周期实现创面闭合与愈合。
- 识别出多种闭合技术,包括即刻闭合、使用内置负压伤口治疗作为临时桥接的加速分期闭合、『回收』皮肤移植及将碘仿纱条再利用作为即刻闭合的辅助治疗。
- 作者认为手术是化脓性汗腺炎的有效疗法,所描述的技术可为未来前瞻性研究和循证指南提供基础。
核心结论
- 这项大型多机构回顾性病历审查表明手术是化脓性汗腺炎的有效疗法,并捕捉了多种部位特异性技术,可作为未来前瞻性研究和循证指南的基础。
研究设计与样本
- 作者对2005年至2020年间在布莱根妇女医院和杜兰大学医学中心接受手术切除治疗的化脓性汗腺炎患者进行了回顾性病历审查。
- 将同一住院期间相关的手术病例组织为治疗周期,并评估患者人口统计学、手术技术和结局。
- 共识别181例患者、435例次手术和316个治疗周期(布莱根妇女医院 n=269;杜兰大学医学中心 n=47)。
主要发现
- 两机构系列患者人口统计学具有可比性,合并治疗周期中94%在研究期间实现创面闭合与愈合。
- 识别出多种闭合技术,包括即刻闭合和部位特异性方法,如使用内置负压伤口治疗作为临时桥接的加速分期闭合、『回收』皮肤移植,以及将碘仿纱条再利用作为即刻闭合的辅助创面愈合治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hidradenitis suppurativa is a chronic inflammatory condition that presents a challenging reconstructive problem for plastic surgeons. METHODS: The authors performed a retrospective chart review of hidradenitis suppurativa patients managed with surgical excision between 2005 and 2020 at Brigham and Women's Hospital and Tulane University Medical Center. Operative cases associated with the same hospitalization were organized into treatment episodes and assessed for patient demographics, operative techniques, and outcomes. RESULTS: A total of 181 patients, 435 cases and 316 treatment episodes (Brigham and Women's Hospital, n = 269; Tulane University Medical Center, n = 47), were identified across two diverse institutions. Their respective series showed comparable patient demographics, and 94 percent of the combined episodes achieved wound closure and healing during the study period. Several techniques of closure were identified, including immediate closure and site-specific methods, such as an expedited staged closure using internal negative-pressure wound therapy as a temporary bridge, "recycled" skin grafting, and repurposing iodoform wicks as an adjunct wound healing therapy to immediate closure. CONCLUSIONS: This large multi-institutional retrospective chart review on the plastic surgical management of hidradenitis suppurativa demonstrates that surgery is an effective therapy for hidradenitis suppurativa and captures a diversity of site-specific techniques that may serve as a foundation for future prospective studies and evidence-based guidelines for the use of various techniques to optimize patients' surgical outcomes. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Hamaguchi R, Wearda TL, Volk AS, et al. Surgical Management of Hidradenitis Suppurativa: A Two-Center Retrospective Study. Plast Reconstr Surg. 2022. PMID: 36288254. doi:10.1097/PRS.0000000000009658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。